27 related articles for article (PubMed ID: 38573391)
1. Development of a Risk Model and Genotyping Patterns Based on Disulfidptosis-Related lncRNAs to Predict Prognosis and Immune Landscape in Osteosarcoma.
Zhang K; Lu S; Jiang M; Zou X; Chen C; Lan Y; Zhao H; Ma R; Yan H
Front Biosci (Landmark Ed); 2024 May; 29(5):193. PubMed ID: 38812298
[TBL] [Abstract][Full Text] [Related]
2. Construction of a novel disulfidptosis-related lncRNAs signature for prognosis prediction and anti-tumor immunity in laryngeal squamous cell carcinoma.
Zhang M; Sun Q; Han Z; Qin X; Gao T; Xu Y; Han S; Zhang Y; Liang Q; Guo Z; Liu J
Heliyon; 2024 May; 10(10):e30877. PubMed ID: 38774325
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer subtyping and immune landscape analysis based on natural killer cell-related genes.
Ding M; Gao J; Wang J; Li Z; Gong X; Cui Z; Li C; Xue H; Li D; Wang Y
Arab J Gastroenterol; 2024 May; 25(2):150-159. PubMed ID: 38719664
[TBL] [Abstract][Full Text] [Related]
4. Identifying disulfidptosis subtypes in hepatocellular carcinoma through machine learning and preliminary exploration of its connection with immunotherapy.
Chen G; Zhang G; Zhu Y; Wu A; Fang J; Yin Z; Chen H; Cao K
Cancer Cell Int; 2024 Jun; 24(1):194. PubMed ID: 38831301
[TBL] [Abstract][Full Text] [Related]
5. A novel disulfidptosis-related gene signature predicts overall survival of glioblastoma patients.
Zhang Y; Liu B; Zhou Y
Future Sci OA; 2024; 10(1):FSO948. PubMed ID: 38817361
[TBL] [Abstract][Full Text] [Related]
6. Unveiling the role of disulfidptosis-related genes in the pathogenesis of non-alcoholic fatty liver disease.
Luo X; Guo J; Deng H; He Z; Wen Y; Si Z; Li J
Front Immunol; 2024; 15():1386905. PubMed ID: 38812509
[TBL] [Abstract][Full Text] [Related]
7. RNA sequencing-based approaches to identifying disulfidptosis-related diagnostic clusters and immune landscapes in osteoporosis.
Zhang P; Li B; Chen H; Ge Z; Shang Q; Liang D; Yu X; Ren H; Jiang X; Cui J
Aging (Albany NY); 2024 May; 16(9):8198-8216. PubMed ID: 38738994
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization, clinical value, and cancer-immune interactions of genes related to disulfidptosis and ferroptosis in colorectal cancer.
Liu X; Li D; Gao W; Chen P; Liu H; Zhao Y; Zhao W; Dong G
Discov Oncol; 2024 May; 15(1):183. PubMed ID: 38787520
[TBL] [Abstract][Full Text] [Related]
9. Collagen-related gene expression level predicts the prognosis and immune therapy response.
Wang J; Liu Z; Lin L; Wu Z; Gao X; Cai X; Chang L; Xia X; Zhang H; Chen G
Gastric Cancer; 2023 Nov; 26(6):891-903. PubMed ID: 37543986
[TBL] [Abstract][Full Text] [Related]
10. Development of stemness-related signature to optimize prognosis prediction and identify XMD8-85 as a novel therapeutic compound for glioma.
Niu W; Yu H; Fan X; Li S; Sun S; Gong M; Zhang S; Bi W; Chen X; Fang Z
Cell Signal; 2024 May; 120():111231. PubMed ID: 38768760
[TBL] [Abstract][Full Text] [Related]
11. Constitutive type-1 interferons signaling activity in malignant gliomas.
Li C; Long L; Wang Y; Chi X; Zhang P; Zhang Y; Ji N
J Neurooncol; 2024 May; ():. PubMed ID: 38789844
[TBL] [Abstract][Full Text] [Related]
12. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
13. Construction of disulfidptosis-based immune response prediction model with artificial intelligence and validation of the pivotal grouping oncogene c-MET in regulating T cell exhaustion.
Li P; Wang S; Wan H; Huang Y; Yin K; Sun K; Jin H; Wang Z
Front Immunol; 2024; 15():1258475. PubMed ID: 38352883
[TBL] [Abstract][Full Text] [Related]
14. The disulfidptosis-related signature predicts prognosis and immune features in glioma patients.
Wang X; Yang J; Yang F; Mu K
Sci Rep; 2023 Oct; 13(1):17988. PubMed ID: 37864127
[TBL] [Abstract][Full Text] [Related]
15. Development and experimental verification of a prognosis model for disulfidptosis-associated genes in HNSCC.
Li Y; Tao L; Xin J; Dai Y; Chen X; Zou J; Wang R; Wang B; Liu Z
Medicine (Baltimore); 2024 Mar; 103(12):e37308. PubMed ID: 38518012
[TBL] [Abstract][Full Text] [Related]
16. Signature Construction and Disulfidptosis-Related Molecular Cluster Identification for Better Prediction of Prognosis in Glioma.
Zhuang Y; Chen J; Mai Z; Huang W; Zhong W
J Mol Neurosci; 2024 Apr; 74(2):38. PubMed ID: 38573391
[TBL] [Abstract][Full Text] [Related]
17. Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer.
Liang J; Wang X; Yang J; Sun P; Sun J; Cheng S; Liu J; Ren Z; Ren M
Front Immunol; 2023; 14():1198826. PubMed ID: 38035071
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
